Tolerance and Benefits of Mandibular Advanced Device for Snoring and Sleep Apnea in Oropharyngeal Cancer.
Recruiting
N/A
Interventional Study
Oral Cancer
Pharynx Cancer
Sleep Apnea
Snoring
Oral Squamous Cell Carcinoma
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 65
- Sex
- Any
- Study type
- Interventional
- Purpose
- Supportive Care
- Participants needed
- 35 (estimated)
- Sponsor
- Centre hospitalier de l'Université de Montréal (CHUM) · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Evaluation of the Tolerance and Benefits of Mandibular Advanced Device (MAD) for Snoring and Sleep Apnea in Patients with Oropharyngeal Cancer (OPC): Mixed Design Study.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* oropharyngeal cancer diagnosis
* 18 years of age and over
* female or male; ratio of 1/4 toward men
* had received RTH in the Department of Radiation Oncology,
* reporting snoring and/or respiratory cessation complaints during sleep,
Exclusion Criteria:
* pregnant or breastf…
Contacts